Type 1 diabetes

Thyroid, Celiac, and Other Autoimmune Diseases and the Risk of Incident Type 1 Diabetes in Young Adulthood

Diabetes CarePublished Population-based cohort study

Main finding · Incident T1DResult — go to the resultHazard ratio 2.19 95% CI 1.57–3.04

Authors' conclusion

Autoimmune diseases in late adolescence were associated with an increased risk of T1D in adulthood in both sexes, especially among those with AITD and celiac disease.

Study context

Population
Israeli adolescents aged 16–19 years without a history of dysglycemia, evaluated before mandatory military service, January 1996–December 2016
Participants
1,426,362 adolescents15,810,751 person-years
Exposure
Any autoimmune disease vs no autoimmunity
  • Autoimmunityn = 38,766
Outcome
Incident adult-onset T1D
Methodological detailsnationwide, linked to Israeli National Diabetes Registry, Cox proportional hazards modeling
  • Nationwide
  • Linked to Israeli National Diabetes Registry
  • Cox proportional hazards modeling

Main finding

Incident T1D

Hazard ratio

2.19

95% CI 1.57–3.04

Events by group

Autoimmunity

9.6 cases per 105 person-years

37 of 38,766

No autoimmunity

4.8 cases per 105 person-years

740 events

Autoimmunityvs No autoimmunity
HR 2.19 (95% CI 1.57–3.04)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR
Incident T1D with islet autoantibodies as mandatory case-definition criteria2.22 (95% CI 1.13–4.35)
Incident T1D by autoimmune disease: AITD (n=10,333) and celiac disease (n=9,603)AITDvs No autoimmunity3.99 (CI 2.5–6.4)
Incident T1D by autoimmune disease: AITD (n=10,333) and celiac disease (n=9,603)Celiac diseasevs No autoimmunity2.82 (CI 1.46–5.45)

Original publication

Thyroid, Celiac, and Other Autoimmune Diseases and the Risk of Incident Type 1 Diabetes in Young Adulthood. Diabetes Care. Published 15 October 2025. doi:10.2337/dc25-1423

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.